Operating
Impairment Charges
This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalLower is better
VolatilityVolatile
First reportedQ1 2015
Last reportedQ4 2025
How to read this metric
High impairment charges suggest poor capital allocation or a decline in the competitive value of the company's assets.
Detailed definition
Impairment charges are non-cash write-downs taken when the carrying value of an asset exceeds its fair market value. Thi...
Peer comparison
Common in industries with high intangible asset bases, such as pharma and consumer goods.
Metric ID:
cf_impairment_chargesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $2.70B | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $50.00M | $2.43B | $0.00 | $1.75B | $0.00 | $0.00 | $190.00M | $0.00 | $400.00M |
| QoQ Change | — | — | — | — | -100.0% | — | — | — | — | — | — | >999% | -100.0% | — | -100.0% | — | — | -100.0% | — |
| YoY Change | — | — | — | — | — | — | — | -100.0% | — | — | — | — | — | — | -100.0% | -100.0% | — | -100.0% | — |
Range$0.00 – $2.70B
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Impairment Charges at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's impairment charges?
- Gilead Sciences (GILD) reported impairment charges of $400.00M in Q4 2025.
- What does impairment charges mean?
- A non-cash charge taken when an asset is determined to be worth less than its recorded value.